ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,730, issued on Oct. 14, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"PRMT5 inhibitors" was invented by Michelle Machacek (Belmont, Mass.), Michael D. Altman (Needham, Mass.), Shuhei Kawamura (Cambridge, Mass.), Michael H. Reutershan (Brighton, Mass.), David L. Sloman (Newton, Mass.), Phieng Siliphaivanh (Newton Highlands, Mass.), Sebastian E. Schneider (Boston), Charles S. Yeung (Dedham, Mass.), David J. Witter (Ontario, Canada) and Craig R. Gibeau (Northborough, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of Formula (I) (I) and the pharmaceutically acceptable salts, esters, and prodrugs...